ROYMANS, Dirk André Emmy,KOUL, Anil,YSEBAERT, Nina,GOEYVAERTS, Nele Isa E.
申请号：
CL2020001429
公开号：
CL2020001429A1
申请日:
2020.05.28
申请国别(地区):
CL
年份:
2020
代理人:
摘要：
T. N refers to the mixture of Ci and amp； oacute； n refers to the VR inhibitor compound, namely 3 - ({5-chloro-1 - [3 - (methylthio) propyl] - 1-1 - (2, 2, 2-trifluoroethane) - 1, 3-dihydromethylmethylmethylhihihidiazzo [4, 5-c] piridin-2-ona, 1 -, while B refers to a compound, while B refers to a compound, while B refers to a substance (a substance is a substance, while another substance, a substance, a kind of a substance), B refers to a substance (a kind of substance, while another substance, a substance, a kind of a substance), while B refers to a kind of substance, while B refers to a substance (a kind of substance, while another substance, a substance, a substance, a substance, and B refers to a substance (a substance, a matter, that is: a kind of substance is a kind of substance, a kind of substance is a kind of substance, that is, a kind of substance, that is, a kind of substance, that is, a kind of 1s, 2 (s) - 2 - [4 - [7-cyclopapil5 - [1 (R) - 1-meth-3, 4-dihydro-1h-isoquinlino-2-carbonil] pirazolo [1, 5-a] pirimidin-2-il] - 3-fluorophonil] cyclopabox amp； Iacute； licopa was used to treat or improve infacci amp； oacute； n VR. Invention amp； oacute； n refers to ADEM amp； Aacute； s refers to the combined product of compound A and compound B,a. Drug and amp； eacute； including the use of complex a and complex B, the use of CI amp； oacute, N complex a and B (or prescription and amp product； eacute； oacute； n including VCR and UN M amp； eacute； eacute； n includes VCR and UN M amp； eacute； a. All are used for the treatment or improvement of infected persons and the role of amp； oacute； n for VSR in a required subject, including the management of effective quantities of CI amp； oacute； n for compound A and compound B； for that subject； lt； P gt；<；p>；La presente invenció；n se refiere a la combinació；n del Compuesto A inhibidor del VSR, es decir, 3-({5-cloro-1-[3-(metilsulfonil)propil]-1H-indol-2-il}metil)-1-(2,2,2-trifluoroetil)-1,3-dihidr
